Copyright
©The Author(s) 2015.
World J Psychiatr. Dec 22, 2015; 5(4): 366-378
Published online Dec 22, 2015. doi: 10.5498/wjp.v5.i4.366
Published online Dec 22, 2015. doi: 10.5498/wjp.v5.i4.366
n | Treatments | Diagnosis | Response rates | |
Avoidance model | ||||
Integrative therapy | 24 | CBT + SL vs CBT + I/EP | GAD | CBT + SL = 66.7% |
Newman et al[16] | 14 sessions | CBT + I/EP = 83.3% | ||
Intolerance of uncertainty model | ||||
Ladouceur et al[81] | 26 | CBT vs wait list | GAD | CBT = 77% |
Metacognitive model | ||||
Wells and King[19] | 10 | MCT | GAD | 87.5% |
MCT = 80% | ||||
Wells et al[20] | 20 | MCT vs AR | GAD | AR = 10% |
Acceptance based model | ||||
Roemer et al[23] | 31 | ABBT vs wait list | GAD | ABBT = 78% |
Wait list = 17% | ||||
TDCRP | ||||
Elkin et al[34] | 50 | CBT | CBT = 40%; 58% | |
56 | IPT | MDD | IPT = 47%; 60% | |
49 | IMI-CM | IMI = 49%; 61% | ||
50 | PLA-CM | PLA = 26%; 50% | ||
Cognitive model | ||||
Thoma et al[28] (meta-anlaysis) | 29 | CBT vs wait list | MDD/minor depression/dysthymia | ES = 0.90 |
18 | CBT vs TAU | ES = 0.40 | ||
26 | CBT vs other1 | ES = 0.05 | ||
23 | CBT vs medication | ES = 0.10 | ||
Behavioral activation | ||||
Dimidjian et al[31] | 45 | CT | High severity | |
43 | BA | MDD | CT = 56%; 48% | |
100 | ADM | BA = 60%; 76% | ||
53 | PLA | High and low severity | ADM = 40%, 49% | |
Interpersonal psychotherapy model | 26 wk | |||
Peeters et al[37] | 63 | CT | MDD | CT = 41%; ES = 1.3 |
56 | IPT | Nonrandomized trial | IPT = 39%; ES = 1.5 | |
34 | CT-PHT | CT-PHT = 35%; ES = 1.0 | ||
21 | IPT-PHT | IPT-PHT = 33%; ES = 1.0 |
- Citation: Coplan JD, Aaronson CJ, Panthangi V, Kim Y. Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches. World J Psychiatr 2015; 5(4): 366-378
- URL: https://www.wjgnet.com/2220-3206/full/v5/i4/366.htm
- DOI: https://dx.doi.org/10.5498/wjp.v5.i4.366